Product Pathways - TGF-beta/Smad Signaling
Human BMP2 #4697
|4697S||10 µg||---||In Stock||---|
|26 kDa||Recombinant human BMP-2 was expressed in E. coli and is supplied in a lyophilized form. A greater than 95% purity was determined by reverse-phase HPLC and SDS-PAGE.||>95%|
Concentration and Specific Activity
10 μg lyophilized, ED50 less than 50 ng/ml
Directions For Use
The working concentration of BMP-2 generally ranges from 20-50 ng/ml.
Bone morphogenetic proteins (BMPs) were first identified as molecules that can induce ectopic bone and cartilage formation (1,2). BMPs are synthesized as precursor proteins that are processed by cleavage to produce mature proteins. BMPs initiate signaling by binding to a receptor complex containing type I and type II serine/threonine receptor kinases that then phosphorylate Smad (mainly Smad1, 5 and 8), resulting in the translocation of Smad to the nucleus. BMP was also reported to activate MAPK pathways in some systems (3,4).
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 7074 Anti-rabbit IgG, HRP-linked Antibody
- 4693 BMP7 Antibody
- 7727 Biotinylated Protein Ladder Detection Pack
- 9516 Phospho-Smad1/5 (Ser463/465) (41D10) Rabbit mAb
- 6883 SignalFire™ ECL Reagent
- 12757 SignalFire™ Elite ECL Reagent
- 12630 SignalFire™ Plus ECL Reagent
- 9743 Smad1 Antibody
- 9517 Smad5 Antibody
This product is intended for research purposes only. The product is not intended to be used for therapeutic or diagnostic purposes in humans or animals.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.